[PDF] Top 20 Metaheurísticas aplicadas al problema de ruteo de vehículos
Has 6964 "Metaheurísticas aplicadas al problema de ruteo de vehículos" found on our website. Below are the top 20 most common "Metaheurísticas aplicadas al problema de ruteo de vehículos".
Evidence-based guideline: Pharmacologic treatment of chorea in Huntington diseaseReport of the Guideline Development Subcommittee of the American Academy of Neurology
... The American Academy of Neurology is committed to producing inde- pendent, critical and truthful clinical practice guidelines ...of, guideline proj- ects. Drafts of the guideline have ... See full document
11
Evidence-based guideline update: Medical treatment of infantile spasmsReport of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
... ACTH imposes a burden of treatment because of its cost and mode of administration (IM). Cost can be pro- hibitive, particularly in the United States. Factors affect- ing cost are varied and complex and include ... See full document
13
Practice guideline update summary: Pharmacologic treatment for pediatric migraine preventionReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
... the Guideline Development, Dissemi- nation, and Implementation Subcommittee by the American Academy of Neurology ...migraine treatment, from the Migraine Research ... See full document
12
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MSReport of the Guideline Development Subcommittee of the American Academy of Neurology
... ∘ What are the risk factors for suicidal thinking and behavior among individuals with MS? We included these questions at the outset because they are clinically relevant: individuals with MS may have psychotic disorders ... See full document
10
Evidence-based guideline update: Steroids and antivirals for Bell palsyReport of the Guideline Development Subcommittee of the American Academy of Neurology
... RECOMMENDATIONS FOR FUTURE RESEARCH It is unlikely that additional research regarding the efficacy of steroids will change the current estimate of its effect. Large randomized trials comparing outcomes in patients with ... See full document
29
Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob diseaseReport of the Guideline Development Subcommittee of the American Academy of Neurology
... the American Acad- emy of Neurology classification of evidence scheme for diagnostic studies, and recommendations were linked to the strength of the ... See full document
7
Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsyReport of the Guideline Development Subcommittee of the American Academy of Neurology
... scales by t tests showed improvements in the clinician- administered Cornell Dysthymia Rating Scale (p 5 0.001) and the patient self-report Beck Depression Inventory (BDI) (p 5 0.045); results on the clinician- ... See full document
6
Evidence-based guideline: Management of an unprovoked first seizure in adultsReport of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society
... the American Academy of Neurology and its affiliates are assessments of current scientific and clinical information pro- vided as an educational ...recent evidence (new evidence may ... See full document
11
Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillationReport of the Guideline Development Subcommittee of the American Academy of Neurology
... warfarin treatment is associated with a decreased risk of stroke or systemic thromboembolism among patients with non–end-stage CKD but that warfarin treatment may be associated with an increased bleeding ... See full document
21
Evidence-based guideline update: Treatment of essential tremorReport of the Quality Standards Subcommittee of the American Academy of Neurology
... OF EVIDENCE Pharmacologic agents without evidence to change the conclusions or recom- ...previous guideline and rated better than Class IV that examined the efficacy and safety of propranolol, ... See full document
15
Practice guideline summary: Treatment of restless legs syndrome in adultsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... Group, Huntington Study Group, Auspex, and InSightec; serves on the Neurology Level of Evidence editorial advisory board; and receives royalties for co-editing the UpToDate publication Restless Legs ... See full document
8
Practice guideline update summary: Acute treatment of migraine in children and adolescentsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
... 2011 evidence-based methodology, as ...2004 guideline that were previously rated as Class I or II were reclassified using the 2011 process manual, as amended, and 4 rated as Class III or higher were ... See full document
27
Evidence-based guideline summary: Diagnosis and treatment of limb-girdle and distal dystrophiesReport of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine
... offspring. Treatment of cardiomyop- athy, arrhythmias, and ventilatory failure prolongs life and improves quality of life in patients with other neuromuscular ... See full document
31
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headacheReport of the Guideline Development Subcommittee of the American Academy of Neurology
... 2011 to 2013. C. Comella has received research grants from and has served as a consultant for Allergan Inc., Ipsen Ltd., Merz Pharmaceut- icals, and Revance Pharmaceuticals. M. Green and G. Gronseth report no disclosures ... See full document
6
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adultsReport of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
... Lancet Neurology, and Postgraduate Medicine; and has served as Editor-in-Chief of Headache Currents and as an Associate Editor of Headache; he receives publishing royalties for Wolff ’s Headache, 8th edi- tion ... See full document
18
Evidence-based guideline: Treatment of tardive syndromesReport of the Guideline Development Subcommittee of the American Academy of Neurology
... as treatment because neuroleptics may cause TDS despite masking ...TDS treatment (Level C). Diltiazem should not be considered as TDD treatment (Level B); galantamine and eicosapen- taenoic acid may ... See full document
9
Evidence-based guideline: Treatment of parenchymal neurocysticercosisReport of the Guideline Development Subcommittee of the American Academy of Neurology
... The American Academy of Neurology is committed to producing independent, critical, and truthful clinical practice guidelines ...the guideline have been reviewed by at least 3 AAN committees, a ... See full document
9
Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular diseaseReport of the Guideline Development Subcommittee of the American Academy of Neurology
... insufficient evidence to support or refute periprocedural heparin bridging therapy to reduce thromboembolic events in chronically anticoagulated patients (Level ...U). Neurology â 2013;80:2065 – ... See full document
14
Practice guideline update summary: Mild cognitive impairmentReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... the American Academy of Neurology (AAN) and its affiliates are assess- ments of current scientific and clinical information provided as an educational ...recent evidence (new evidence may ... See full document
16
Evidence-based guideline update: Plasmapheresis in neurologic disordersReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... gammopathy, based on at least one Class I or 2 Class II studies (Level ...gammopathy, based on one Class I study (Level ...insufficient evidence to support or refute the use of plasmaphere- sis for ... See full document
27
Related subjects